Releuko 70121-1570
Generic: Filgrastim
Product NDC
70121-1570- Manufacturer
- Amneal Pharmaceuticals Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 25, 2022
- Listing Expires
- December 31, 2026
- Application
- BLA761082
Need to source Releuko? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Filgrastim | 480 ug/.8mL |
Drug Class
Leukocyte Growth Factor [EPC]Granulocyte Colony-Stimulating Factor [CS]Increased Myeloid Cell Production [PE]
Packaging Options(2)
1 SYRINGE in 1 BOX (70121-1570-1) / .8 mL in 1 SYRINGE
10 SYRINGE in 1 BOX (70121-1570-7) / .8 mL in 1 SYRINGE